Promoting risk reduction among young adults with asthma during wildfire smoke: A feasibility study.
Julie Marie Postma, Tamara Odom-Maryon, Ana G Rappold and 5 others
PMID 34636066WHAT IT FOUND
Most young adults with asthma completed the 8 week app study; mean usability scores were 81 and 83 out of 100, but lung function fell in SSU-Plus while control symptoms improved, so efficacy is not established.
Key findings
01Enrollment and retention exceeded hypothesized feasibility targets: 83% of eligible participants enrolled and 96% completed week 8.
02In SSU-Plus, the Asthma Control Test score increased from 20.0 to 21.5 (p = .0008), while percent predicted FEV1 decreased from 94.9 to 88.6 (p = .0172).
03The SSU arm showed no significant change in asthma control or lung function, while the control arm showed a significant increase in asthma control score from 20.2 to 22.4 (p = .0320).
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study was a feasibility trial and was not designed or powered for statistical comparisons between arms. It used a convenience sample recruited from university listservs, with limited racial and ethnic diversity, and asthma and medication use were self-reported. Participants were young adults with mild asthma and, on average, well-controlled asthma at baseline, so results may not apply to more severe asthma. Forty-five percent of participants could not be included in the clinical outcome analysis because measurements were outside the timing window or not taken within one day of each other. Only seven SSU participants were included in the clinical outcome analysis. The trial was unblinded, and participants knew their arm assignment. SSU-Plus features were not fully developed at the start, and app usage tracking began four weeks into the study. Spirometry technique could not be taught face-to-face. Follow-up was only eight weeks, and exposure periods varied. GPS permission was intermittent, location was assumed static between data points, and indoor air quality was not measured.
Declared interests
No conflicts-of-interest declaration is provided in the supplied text. The article is listed as NIH extramural research support, and a technology partner, Urbanova, developed or hosted app components.
The easy way to misread this
Do not conclude that SSU-Plus improves asthma outcomes. This was a feasibility study, the control arm also had a significant increase in asthma control score, and SSU-Plus included several features at once, so the contribution of any single component cannot be separated. Lung function also decreased in that arm.